Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Oral contraceptives may cause hair loss in women.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Oral contraceptives may cause significant hair loss in women.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Oestrogens are key for bone growth during puberty in both boys and girls.

Eflornithine cream effectively reduces women's unwanted facial hair but hair returns if treatment stops.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Stress hormone corticosterone blocks a growth factor to slow down hair stem cell activity and hair growth.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Testosterone may slow down wound healing and increase inflammation.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Spironolactone plus finasteride reduces hirsutism more effectively.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Scientists have created a method to deliver specific cells that can regenerate hair follicles, potentially offering a new treatment for hair loss.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.